Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Researchers analyzed blood markers of stress-related wear and tear on the body among people age 50-plus living with the virus.
The newer tenofovir formulation can raise cholesterol and triglyceride levels, but these changes are reversible.
Non-alcoholic fatty liver disease can lead to more severe, potentially fatal liver diseases, including cirrhosis.
A speedy overview of the major scientific findings presented at the International AIDS Conference in Amsterdam (AIDS 2018)
Truvada appeared to temporarily prevent some weight gain and reduce cholesterol slightly in a recent study.
A small study of Spanish people with HIV taking Prezista (darunavir) found that cholesterol and triglycerides dropped after the switch.
Taking omega-3 fatty acid supplements may lower triglycerides and inflammation.
Cutting standard dose of Kaletra by 30 percent does not change its efficacy at suppressing HIV and it improves lipid levels among children.
Your waist circumference combined with your triglyceride level can help determine if you’re at an increased risk for cardiovascular disease.
AIDS Drug Assistance Programs are providing medications to help manage cardiovascular disease risk factors common among people with HIV.
People taking Kaletra had elevations in triglycerides, but they did not have a related increase in other measures of cardiovascular risk.
Lipitor (atorvastatin) and Crestor (rosuvastatin)—two drugs in the statin family—were about twice as likely as the statin Pravacho...
People on a regimen containing efavirenz (found in Sustiva and Atripla) who have neurological side effects or abnormal cholesterol or triglyce...
People on a regimen containing abacavir saw their cholesterol drop quickly and significantly when they switched to a similar regimen containin...
New research suggests that the protease inhibitor (PI) Reyataz (atazanavir), when boosted by low-dose Norvir (ritonavir), might not improve ca...
The FDA announced a new warning December 3 about a potential link between Lexiva (fosamprenavir) and an increase in heart attacks.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.